Aim is to reduce ‘doctor shopping’ for prescriptions, and to better monitor patients and addicts’ health; potential system highlights data availability
Although New York State is one of over 40 states that has a prescription monitoring program (PMP) to prevent drug abusers from filling multiple subscriptions by fraudulently obtaining scrip sheets or prescriptions, the system takes 15 to 45 days to collect each period’s prescription activity—better than nothing, but not enough to shut down this form of abuse. So, Attorney General Eric Schneiderman, together with two state legislators, has proposed the Internet Tracking for OverPrescribing Act, or I-STOP.
I-STOP would cost only a few million dollars to implement, but could help reduce abuse that costs health care providers (including states) hundreds of millions in healthcare, accidental overdoses, and law enforcement activities. The lower-cost options require pharmacists to input data to a centralized state server; other system could eventually involve e-prescribing or financial reconciliation practices in today’s healthcare system.
“We should not think of I-STOP only as a law enforcement tool,” writes Schneiderman. “ I-STOP will also be a diagnostic tool. The very same enhanced communication aspect … will also help [doctors] evaluate a patient’s prescription drug history as part of determining the proper treatment for that patient.” And, while significant communications, data security and privacy issues would need to be worked out, the possibilities for such real-time monitoring of non-controlled substances—for, for instance, medication adherence—are intriguing.
Schneiderman’s report is available here. No word on how far this has advanced in the New York State legislature.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.